GSE Systems Reports Second Quarter 2024 Financial Results
Q2 2024 and Recent Highlights
- Improved gross profit growth driven by Engineering segment, with a 14% increase over Q1 of 2024 and Q2 of 2023.
- Achieved positive Adjusted EBITDA for the first half of 2024, due to continued strong performance from our Engineering segment and diligent operating expense management.
- Backlog at
June 30, 2024 , was$34.7 million , including$30.4 million of Engineering backlog, and$4.3 million of Workforce Solutions backlog. - Ended Q2 with cash, cash equivalents and restricted cash of
$2.7 million , including restricted cash of$1.5 million . - Subsequent to Q2 end, GSE entered into definitive merger agreement to be acquired by Pelican Energy Partners.
Management Commentary
Q2 2024 FINANCIAL RESULTS
Revenue during Q2 2024 was
Engineering revenue was
Workforce Solutions revenue was
Gross profit in Q2 2024 was
Operating expenses in Q2 2024 were
Operating income (loss) was approximately
Net loss in Q2 2024 was
Adjusted net income1 totaled
Earnings before interest, taxes, depreciation and amortization ("EBITDA") for Q2 2024 was approximately
Adjusted EBITDA1 totaled
Backlog at
1 Refer to the non-GAAP reconciliation tables at the end of this press release for a definition of "EBITDA", "adjusted EBITDA" and "adjusted net income".
CONFERENCE CALL
Due to the impending transaction with Pelican, GSE Systems will not be conducting a conference call.
ABOUT GSE SOLUTIONS
Proven by more than 50 years of experience in the nuclear power industry, GSE knows what it takes to help customers deliver carbon-free electricity safely and reliably. Today, GSE Solutions leverages top talent, expertise, and technology to help energy facilities achieve next-level power plant performance. GSE's advanced Engineering and Workforce Solutions divisions offer highly specialized training, engineering design, program compliance, simulation, and technical staffing that reduce risk and optimize plant operations. With more than 1,100 installations and hundreds of customers in over 50 countries, GSE delivers operational excellence. www.gses.com.
FORWARD LOOKING STATEMENTS
We make statements in this press release that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. These statements reflect our current expectations concerning future events and results. We use words such as "expect," "intend," "believe," "may," "will," "should," "could," "anticipates," and similar expressions to identify forward-looking statements, but their absence does not mean a statement is not forward-looking. These statements are not guarantees of our future performance and are subject to risks, uncertainties, and other important factors that could cause our actual performance or achievements to be materially different from those we project. For a full discussion of these risks, uncertainties, and factors, we encourage you to read our documents on file with the Securities and Exchange Commission, including those set forth in our periodic reports under the forward-looking statements and risk factors sections. We do not intend to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Company Contact | Investor Contact | |
Lytham Partners | ||
Chief Executive Officer | ||
GSE Systems, Inc. | (646) 829-9702 | |
(410) 970-7800 |
GSE SYSTEMS, INC. AND SUBSIDIARIES Condensed Consolidated Statements of Operations (in thousands, except share and per share data) | ||||||||||||
Three Months ended | Six Months ended | |||||||||||
June 30, | ||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | |||||||||
Revenue | ||||||||||||
Cost of revenue | 8,051 | 9,172 | 16,118 | 17,650 | ||||||||
Gross profit | 3,674 | 3,215 | 6,890 | 5,610 | ||||||||
Selling, general and administrative | 3,070 | 3,653 | 7,430 | 8,441 | ||||||||
Research and development | 118 | 154 | 347 | 335 | ||||||||
Restructuring charges | 64 | - | 64 | - | ||||||||
Depreciation | 50 | 53 | 108 | 101 | ||||||||
Amortization of definite-lived intangible assets | 83 | 131 | 182 | 292 | ||||||||
Total operating expenses | 3,385 | 3,991 | 8,131 | 9,169 | ||||||||
Operating income (loss) | 289 | (776) | (1,241) | (3,559) | ||||||||
Interest expense, net | (258) | (767) | (717) | (1,053) | ||||||||
Change in fair value of derivative instruments, net | (736) | 171 | (753) | 240 | ||||||||
Other (loss) income, net | (47) | (98) | 7 | (88) | ||||||||
Loss before income taxes | (752) | (1,470) | (2,704) | (4,460) | ||||||||
Expense (benefit) from income taxes | 102 | 28 | 142 | (11) | ||||||||
Net loss | ||||||||||||
Net (loss) income per common share - basic | ||||||||||||
Weighted average shares outstanding - basic | 3,258,124 | 2,418,827 | 3,203,465 | 2,356,413 | ||||||||
GSE SYSTEMS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) | |||||
(unaudited) | (audited) | ||||
ASSETS | |||||
Current assets: | |||||
Cash and cash equivalents | $ | 1,254 | $ | 2,250 | |
Restricted cash, current | 379 | 378 | |||
Contract receivables, net of allowance for credit loss | 9,391 | 10,166 | |||
Prepaid expenses and other current assets | 553 | 879 | |||
Total current assets | 11,577 | 13,673 | |||
Equipment, software and leasehold improvements, net | 650 | 754 | |||
Software development costs, net | 761 | 750 | |||
Goodwill | 4,908 | 4,908 | |||
Intangible assets, net | 997 | 1,179 | |||
Restricted cash - long term | 1,086 | 1,083 | |||
Operating lease right-of-use assets, net | 297 | 413 | |||
Other assets | 45 | 45 | |||
Total assets | $ | 20,321 | $ | 22,805 | |
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||
Current liabilities: | |||||
Current portion of long-term note | 1,200 | 810 | |||
Accounts payable | 2,388 | 3,300 | |||
Accrued expenses | 1,768 | 1,053 | |||
Accrued legal settlements | 529 | 1,010 | |||
Accrued compensation | 2,146 | 1,086 | |||
Billings in excess of revenue earned | 4,974 | 5,119 | |||
Accrued warranty | 166 | 176 | |||
Income taxes payable | 1,776 | 1,701 | |||
Derivative liabilities | 1,861 | 1,132 | |||
Other current liabilities | 358 | 956 | |||
Total current liabilities | 17,166 | 16,343 | |||
Long-term note, less current portion | - | 637 | |||
Operating lease liabilities, noncurrent | 301 | 357 | |||
Other noncurrent liabilities | 80 | 126 | |||
Total liabilities | 17,547 | 17,463 | |||
Commitments and contingencies (Note 12) | |||||
Stockholders' equity: | |||||
Preferred stock | - | - | |||
Common stock | 34 | 32 | |||
Additional paid-in capital | 87,253 | 86,983 | |||
Accumulated deficit | (81,554) | (78,708) | |||
Accumulated other comprehensive income | 40 | 34 | |||
Treasury stock at cost, 159,891 shares | (2,999) | (2,999) | |||
Total stockholders' equity | 2,774 | 5,342 | |||
Total liabilities and stockholders' equity | $ | 20,321 | $ | 22,805 | |
EBITDA and Adjusted EBITDA Reconciliation (in thousands)
References to "EBITDA" mean net (loss) income, before considering interest expense, expense (benefit) from provision for income taxes, depreciation and amortization. References to Adjusted EBITDA excludes stock-based compensation expense and the impact of the change in fair value of derivative instruments. EBITDA and Adjusted EBITDA are not measures of financial performance under
Three Months ended | Six Months ended | |||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | |||||||||||
Net loss | ||||||||||||||
Interest expense, net | 258 | 767 | 717 | 1,053 | ||||||||||
Expense (benefit) from income taxes | 102 | 28 | 142 | (11) | ||||||||||
Depreciation and amortization | 228 | 267 | 487 | 560 | ||||||||||
EBITDA | (266) | (436) | (1,500) | (2,847) | ||||||||||
Stock-based compensation expense | (274) | 246 | 20 | 531 | ||||||||||
Change in fair value of derivative instruments, net | 736 | (171) | 753 | (240) | ||||||||||
Restructuring charges | 64 | - | 64 | - | ||||||||||
Advisory fees | 300 | - | 776 | - | ||||||||||
Adjusted EBITDA | ||||||||||||||
Adjusted Net Income (Loss) and Adjusted EPS Reconciliation (in thousands, except per share amounts)
References to Adjusted Net Income (Loss) excludes the stock-based compensation expense, the impact of the change in fair value of derivative instruments, and amortization of intangible assets. Adjusted Net Income (Loss) and Adjusted Income (Loss) per Share (adjusted EPS) are not measures of financial performance under
Three Months ended | Six Months ended | |||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | |||||||||||
Net loss | ||||||||||||||
Stock-based compensation expense | (274) | 246 | 20 | 531 | ||||||||||
Change in fair value of derivative instruments, | 736 | (171) | 753 | (240) | ||||||||||
Restructuring charges | 64 | - | 64 | - | ||||||||||
Advisory fees | 300 | - | 776 | - | ||||||||||
Amortization of intangible assets related to | 83 | 131 | 182 | 292 | ||||||||||
Adjusted net income (loss) | 55 | (1,292) | (1,051) | (3,866) | ||||||||||
Net loss per common share - diluted | (0.26) | (0.62) | (0.89) | (1.89) | ||||||||||
Add back: Effect of stock-based compensation | (0.08) | 0.11 | 0.01 | 0.24 | ||||||||||
Add back: Effect of change in fair value of | 0.22 | (0.07) | 0.23 | (0.11) | ||||||||||
Add back: Effect of restructuring charges | 0.02 | - | 0.02 | - | ||||||||||
Add back: Effect of advisory fees | 0.09 | - | 0.24 | - | ||||||||||
Add back: Effect of amortization of intangible | 0.03 | 0.05 | 0.06 | 0.12 | ||||||||||
Adjusted net income (loss) per common share – | ||||||||||||||
Weighted average shares outstanding – diluted(1) | 3,258,124 | 2,418,827 | 3,148,806 | 2,293,389 | ||||||||||
(1) During the three and six months ended |
View original content to download multimedia:https://www.prnewswire.com/news-releases/gse-systems-reports-second-quarter-2024-financial-results-302222774.html
SOURCE GSE Systems, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
- Brenmiller Energy signs term sheet for land in Hungary
- Edgewise sells muscular dystrophy drug to Servier for up to $2.65B
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share